HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) major shareholder Of America Corp /De/ Bank sold 477 shares of HCA Healthcare stock in a transaction dated Tuesday, January 10th. The stock was sold at an average price of $21.90, for a total value of $10,446.30. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Major shareholders that own at least 10% of a company's stock are required to disclose their transactions with the SEC.
HCA Healthcare Stock Up 0.1 %
Shares of NYSE:HCA traded up $0.31 during mid-day trading on Tuesday, hitting $345.86. 1,226,315 shares of the company traded hands, compared to its average volume of 1,348,308. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm's 50 day simple moving average is $325.79 and its 200 day simple moving average is $340.25. The firm has a market cap of $85.15 billion, a P/E ratio of 15.74, a PEG ratio of 1.10 and a beta of 1.68.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business posted $5.90 earnings per share. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare's dividend payout ratio is presently 13.11%.
Institutional Trading of HCA Healthcare
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter worth about $39,000. Whipplewood Advisors LLC bought a new stake in HCA Healthcare in the fourth quarter valued at about $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare in the 4th quarter worth approximately $36,000. Activest Wealth Management raised its position in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. boosted its holdings in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after purchasing an additional 50 shares during the period. Institutional investors own 62.73% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on HCA. Barclays reduced their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. Royal Bank of Canada decreased their price target on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday, January 27th. Truist Financial cut their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Finally, Morgan Stanley cut their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a research note on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $385.67.
View Our Latest Stock Analysis on HCA
HCA Healthcare Company Profile
(
Get Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.